A waiver of intellectual property rights on Covid-19 vaccines and drugs alone may not benefit developing countries including India in the battle against the deadly disease. Murali Neelakantan, Former Global General Counsel of Cipla and Glenmark, and Vikas Dandekar, Editor, Pharma and Healthcare, ET Prime, explain what’s at stake for the patent holders and developing nations. The clip featuring Bill Gates used in the podcast belongs to Sky News.